BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 36938794)

  • 1. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
    Mangaonkar AA; Patnaik MM
    Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection and intervention of clonal hematopoiesis for preventing hematological malignancies.
    Ye B; Sheng Y; Zhang M; Hu Y; Huang H
    Cancer Lett; 2022 Jul; 538():215691. PubMed ID: 35469959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clonal hematopoiesis of undetermined potential (CHIP) and clonal cytopenia of unknown significance (CCUS) - Consequences for the clinic].
    Ziemann F; Metzeler KH
    Dtsch Med Wochenschr; 2023 Apr; 148(8):441-450. PubMed ID: 36990116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of clonal hematopoiesis: What has SF3B1-mutant MDS taught us?
    Todisco G; Moura PL; Hellström-Lindberg E
    Semin Hematol; 2022 Jul; 59(3):150-155. PubMed ID: 36115692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premalignant Clonal Hematopoiesis (Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenia of Undetermined Significance).
    Craven KE; Ewalt MD
    Clin Lab Med; 2023 Dec; 43(4):565-576. PubMed ID: 37865503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
    Steensma DP
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101327. PubMed ID: 34865699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms.
    Xie Z; Chen EC; Mendez LM; Komrokji R; Zeidan AM
    Cancer J; 2023 May-Jun 01; 29(3):130-137. PubMed ID: 37195768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and inflammation: A review of mechanisms and clinical implications.
    Nathan DI; Dougherty M; Bhatta M; Mascarenhas J; Marcellino BK
    Crit Rev Oncol Hematol; 2023 Dec; 192():104187. PubMed ID: 37879493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant
    Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
    JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of clonal hematopoiesis.
    Weeks LD; Ebert BL
    Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Game of clones: Diverse implications for clonal hematopoiesis in lymphoma and multiple myeloma.
    Meier J; Jensen JL; Dittus C; Coombs CC; Rubinstein S
    Blood Rev; 2022 Nov; 56():100986. PubMed ID: 35753868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of somatic mutations and clonal hematopoiesis in astronauts.
    Brojakowska A; Kour A; Thel MC; Park E; Bisserier M; Garikipati VNS; Hadri L; Mills PJ; Walsh K; Goukassian DA
    Commun Biol; 2022 Aug; 5(1):828. PubMed ID: 35978153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases.
    Zhang Z; Sun J
    Adv Exp Med Biol; 2023; 1442():65-83. PubMed ID: 38228959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.